Metastatic Colorectal Cancer: Part 1
EP. 1: Ki Chung, MD: Impact of Sensory Neuropathy on Second-Line Treatment
July 10th 2015
EP. 2: Ki Chung, MD: EGFR-Directed Therapy and Mutational Status
July 10th 2015
EP. 3: Ki Chung, MD: Continuation of Anti-Angiogenesis Therapy
July 10th 2015
EP. 4: Ki Chung, MD: Second-Line Options to Prolong Survival
July 10th 2015
EP. 5: Alan Venook, MD: Impact of Sensory Neuropathy on Second-Line Treatment
July 10th 2015
EP. 6: Alan Venook, MD: EGFR-Directed Therapy and Mutational Status
July 10th 2015
EP. 7: Alan Venook, MD: Continuation of Anti-Angiogenesis Therapy
July 10th 2015
EP. 8: Alan Venook, MD: Second-Line Options to Prolong Survival
July 10th 2015
EP. 9: Cathy Eng, MD, FACP: Impact of Sensory Neuropathy on Second-Line Treatment
July 10th 2015
EP. 10: Cathy Eng, MD, FACP: EGFR-Directed Therapy and Mutational Status
July 10th 2015
EP. 11: Cathy Eng, MD, FACP: Continuation of Anti-Angiogenesis Therapy
July 10th 2015
EP. 12: Cathy Eng, MD, FACP: Second-Line Options to Prolong Survival
July 10th 2015
